Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Polish Multidrug-Resistant TB Consilium - A tool to support physicians.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contacts.

IJTLD open·2025
Same author

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe.

IJTLD open·2025
Same author

The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland.

IJTLD open·2025
Same author

Disseminated TB associated with acute severe malnutrition in a Roma child.

IJTLD open·2024
Same author

PREVALENCE OF CHRONIC KIDNEY DISEASE AMONG STEADY STATE SICKLE CELL DISEASE ADULT PATIENTS ATTENDING AHMADU BELLO UNIVERSITY TEACHING HOSPITAL, ZARIA.

West African journal of medicine·2024

Related Experiment Video

Updated: May 12, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011.

I Solovic1, J Jonsson, M Korzeniewska-Koseła

  • 1Catholic University, Ružomberok, Slovakia.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|April 6, 2013
PubMed
Summary

Extrapulmonary tuberculosis (EPTB) diagnosis is challenging in the EU due to varied symptoms and difficulties in sample collection. Low clinical suspicion and rarity of EPTB further complicate accurate and timely diagnosis for patients.

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Related Experiment Videos

Last Updated: May 12, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Area of Science:

  • Medical Diagnostics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) remains a significant public health concern in the European Union (EU).
  • Extrapulmonary tuberculosis (EPTB) constitutes a substantial proportion of notified TB cases, varying significantly across EU Member States.
  • Diagnostic practices and challenges for EPTB are not uniformly understood across the EU/EEA.

Purpose of the Study:

  • To assess and describe the diagnostic procedures for EPTB in EU/EEA countries.
  • To identify and analyze the challenges faced by healthcare professionals in diagnosing EPTB.

Main Methods:

  • A survey was distributed to EU/EEA countries to gather information on EPTB diagnostic practices.
  • Data collection involved reports from participating Member States on diagnostic procedures and encountered challenges.
  • Analysis focused on reported diagnostic steps, tests used, and barriers to diagnosis.

Main Results:

  • In most participating countries, EPTB diagnosis is primarily managed by pulmonologists, often with specialist input for specific organ involvement.
  • Diagnostic pathways typically involve medical history, physical examination, and invasive procedures (e.g., puncture, biopsy) for sample collection and confirmation (culture, histology, cytology).
  • Reported challenges include low clinical suspicion due to EPTB's rarity and non-specific symptoms, and difficulties in obtaining adequate samples for definitive diagnosis.

Conclusions:

  • Diagnosing EPTB presents significant challenges stemming from its diverse clinical presentations, mimicking other diseases.
  • Low index of clinical suspicion among healthcare professionals and difficulties in obtaining appropriate diagnostic samples are major hurdles.
  • Standardizing diagnostic approaches and improving clinician awareness are crucial for effective EPTB management.